Technology-Assisted Language Intervention for Hearing Loss-related Language Delay

(TALI Trial)

Not currently recruiting at 1 trial location
JM
LL
Overseen ByLaura Lane, MPH
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Children's Hospital Medical Center, Cincinnati
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new technology-assisted language tool, Technology-assisted Language Intervention (TALI), to improve language development in children who are deaf or hard of hearing. The researchers aim to determine if this technology enhances communication more effectively than standard speech therapy. Children will be randomly assigned to use this new tool alongside their usual therapy or to continue with their current therapy alone. The trial seeks children aged 3 to 10 with moderate to profound hearing loss and language challenges who are already receiving speech therapy. As an unphased trial, it offers participants a unique opportunity to contribute to innovative research that could significantly enhance language development tools for children.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What prior data suggests that this technology is safe for improving language development in children with hearing loss?

Research has shown that Technology-Assisted Language Intervention (TALI) can improve language skills in children who are deaf or hard of hearing. Although specific safety data is not available, this intervention—using software alongside regular speech-language therapy—is generally considered safe. It employs communication technology, which poses less risk than drug treatments.

Studies have not reported negative effects from using TALI. As a technology-based tool, it is likely easy for children to use without major issues. Overall, TALI appears to be a safe method to help children with hearing loss enhance their language skills.12345

Why are researchers excited about this trial?

Researchers are excited about Technology-Assisted Language Intervention (TALI) because it introduces a tech-savvy approach to tackling language delays due to hearing loss. Unlike traditional speech-language therapy, TALI incorporates augmentative and alternative communication software into the therapy sessions, making the intervention more interactive and engaging for children. This innovative use of technology could potentially enhance language development more effectively than the standard methods, offering a fresh, dynamic way to support kids in their communication journey.

What evidence suggests that Technology-Assisted Language Intervention (TALI) is effective for improving language development in children with hearing loss?

Studies have shown that Technology-assisted Language Intervention (TALI), one of the treatments in this trial, can effectively help children who are deaf or hard of hearing develop their language skills. One study found that children using TALI made significant progress in language, which is crucial for academic success and social interaction. Another study explained that these improvements occur because TALI incorporates visual aids and various communication methods into speech therapy. A structured 24-week program also demonstrated positive results for children with hearing difficulties. Overall, early evidence suggests that TALI is a promising tool for supporting language development in these children. Participants in this trial will receive either TALI or Treatment as Usual, which involves the child's typical speech language therapy without changes to their current care.46789

Who Is on the Research Team?

JM

Jareen Meinzen-Derr

Principal Investigator

Children's Hospital Medical Center, Cincinnati

Are You a Good Fit for This Trial?

This trial is for children aged 3-10 with moderate to profound bilateral hearing loss and a language deficit. They must be receiving speech-language therapy, have an IQ within the normal range, and speak English as their primary language. Children with mild or unilateral hearing loss, severe communication disorders like autism, nonverbal IQ below 80, or significant motor impairments cannot participate.

Inclusion Criteria

You have permanent hearing loss in both ears that is moderate to severe.
I am currently undergoing speech-language therapy.
I am between 3 and 10 years old.
See 1 more

Exclusion Criteria

I have slight hearing loss in one ear.
I have major difficulties with movement.
My child has a severe communication disorder, such as autism.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Children receive either the technology intervention or treatment as usual for language development

24 weeks

Follow-up

Participants are monitored for language development outcomes after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Technology-assisted Language Intervention (TALI)
  • Treatment as usual
Trial Overview The study compares two approaches: one uses technology-assisted language intervention tools designed for deaf or hard of hearing children; the other follows standard treatment without these tools. Kids are randomly assigned to either group to see which method better improves their language skills.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: Technology Assisted Language Intervention (TALI)Active Control1 Intervention
Group II: Treatment as UsualActive Control1 Intervention

Technology-assisted Language Intervention (TALI) is already approved in United States for the following indications:

🇺🇸
Approved in United States as TALI for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Children's Hospital Medical Center, Cincinnati

Lead Sponsor

Trials
844
Recruited
6,566,000+

Published Research Related to This Trial

A study involving 180 children aged 3 to 5 years with mild-to-severe hearing loss found that better aided hearing from hearing aids is significantly associated with improved speech and language development.
The effectiveness of hearing aids was enhanced by the duration of use, indicating that longer experience with hearing aids leads to better outcomes, especially for children with the best aided hearing.
The influence of hearing aids on the speech and language development of children with hearing loss.Tomblin, JB., Oleson, JJ., Ambrose, SE., et al.[2022]
The paper emphasizes the importance of incorporating principles of implicit learning—variability, complexity, and sleep-dependent consolidation—into language treatment designs for children with specific language impairment (SLI) to enhance efficacy.
Current treatments often lack these principles, which are known to positively influence learning in unimpaired learners, suggesting that applying these concepts could lead to more effective interventions for children with SLI.
Using principles of learning to inform language therapy design for children with specific language impairment.Alt, M., Meyers, C., Ancharski, A.[2022]
The study evaluated the Language ENvironment Analysis (LENA) system as a tool for assessing early communication skills in children with cochlear implants (CIs), involving four children aged 6 to 35 months.
Results showed that LENA's measures, such as conversational turns, significantly predicted vocabulary development, suggesting it could be a valuable resource for early assessment and research on cochlear implant outcomes.
Assessment of Communication Abilities in Four Children with Early Bilateral CIs in Clinical and Home Environments with LENA System: A Case Report.Colombani, A., Saksida, A., Pintonello, S., et al.[2022]

Citations

A Technology-Assisted Language Intervention for Children ...This study highlights results of a randomized trial of a novel technology-based intervention to enhance language development in children who are DHH.
Technology assisted language intervention (TALI) for ...Children who are deaf and hard of hearing (DHH) often demonstrate pragmatic language difficulties which can impact academic and social outcomes.
The Effectiveness of Linguistic Intervention in Children With ...Linguistic intervention programs improve the language of children with hearing loss. Most of these interventions include therapies that use visual supports and ...
Technology-assisted Language Intervention (TALI)This study is testing the effectiveness of augmentative and alternative communication technology among deaf or hard of hearing children for ...
Social Validity of Technology Assisted Spoken Language ...Results from our recent study of TALI (Meinzen-Derr et al.,. 2016) in a 24-week structured intervention in five children with bilateral hearing loss found ...
Technology-assisted Language Intervention (TALI)This study is testing the effectiveness of augmentative and alternative communication technology among deaf or hard of hearing children for improving language ...
7.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/37304207/
Technology assisted language intervention (TALI) for children ...Technology assisted language intervention (TALI) for children who are deaf/hard of hearing: promising impact on pragmatic skills · Abstract · Associated data.
Technology Assisted Language Intervention (TALI)The goal of this study is to compare the effectiveness of two speech language therapy approaches on improving language skills of children who are deaf/hard of ...
9.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/33452063/
A Technology-Assisted Language Intervention for Children ...The study objective was to evaluate the impact of the TALI on spoken language outcomes in DHH children. Methods: Children aged 3 to 12 years ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security